Medical Innovation Collaboration Program: From Concept to Market in China

Program Title: QuNaMai International Medical Innovation Partnership

Program Concept: A comprehensive collaboration model that transforms international doctors' innovative medical product ideas into commercially successful products in the Chinese market.

🔁 Collaboration Workflow

1. Innovation Submission & Evaluation

   • International doctors submit their product concepts through QuNaMai's dedicated portal.

   • Joint expert committee (technical, clinical, market) evaluates innovation potential, feasibility, and market fit.

2. Intellectual Property (IP) Assessment & Agreement

   • Clear IP ownership confirmation: The submitting doctor retains all patent rights.

   • Sign confidential disclosure agreement (CDA) and collaboration agreement outlining rights, responsibilities, and royalty structure.

3. Product Development & Prototyping

   • QuNaMai coordinates engineering, design, and manufacturing of functional prototypes.

   • Regular progress updates and feedback loops with the innovating doctor.

4. Regulatory Strategy & Approval (NMPA Registration)

   • QuNaMai's regulatory team manages the entire China NMPA registration process, including:

     • Pre-submission meetings

     • Testing and clinical evaluation (as required)

     • Documentation preparation and submission

     • Liaison with the NMPA

5. Manufacturing, Marketing & Commercialization

   • QuNaMai oversees mass production, quality control, market launch, and nationwide distribution.

   • Implementation of targeted marketing campaigns to Chinese hospitals and surgeons.

6. Sales & Royalty Distribution

   • Transparent sales tracking and reporting.

   • Quarterly royalty payments to the innovator doctor based on agreed percentage of net sales.

💡 Value Proposition for International Doctors

• Turnkey Solution: Eliminates the extreme complexity, cost, and time required to navigate the Chinese regulatory and market landscape independently.

• IP Protection: Your patent is the foundation of the agreement. We help secure and enforce it in China.

• Revenue Share: Earn passive royalty income (e.g., a percentage of sales) without the burden of managing a business in China.

• Clinical Impact: Bring your innovative solution to one of the world's largest medical markets, improving patient care on a massive scale.

• Professional Recognition: Gain international prestige as the inventor of a commercially available product in China.

🛡️ QuNaMai's Responsibilities

• Product Co-Development & Engineering

• Funding for Prototyping, Testing, and Regulatory Submissions

• Full Management of NMPA Registration Process

• Manufacturing Sourcing & Quality Management

• National Marketing, Sales, and Distribution

• Post-Market Surveillance & Compliance

• Royalty Accounting & Transparent Financial Reporting

👨‍⚕️ Innovator Doctor's Rights & Benefits

• Retains 100% Ownership of the Original Patent.

• Grants an Exclusive License to QuNaMai for the Chinese market.

• Receives a Agreed Percentage of Net Sales as royalty (e.g., 5-15%, depending on product type, development complexity, and market potential).

• Recognized as the Inventor on all marketing and packaging materials.

• Has Access to Regular Sales Data and performance reports.

• Potential Role as a key opinion leader (KOL) for product training and promotion in China.

📋 Example Royalty Structure

Rates are negotiable and determined case-by-case during the evaluation phase.

✉️ How to Apply & Next Steps

Interested international doctors are invited to submit their innovation concepts for a preliminary, confidential review.

Required for Initial Submission:

1. Brief description of the innovation and its clinical benefits.

2. Summary of any existing intellectual property (patent filings/numbers).

3. Curriculum Vitae (CV) of the innovator(s).

Contact:
QuNaMai Medical Innovation Committee
Email: [qunamai@163.com]
Subject Line: International Innovation Submission - [Your Name] - [Brief Product Title]

This proposal clearly outlines a mutually beneficial, secure, and professional framework designed to attract high-quality innovations from international doctors by addressing their core concerns: IP protection, fair compensation, and access to the Chinese market.